Product Description
TACEEDO RTU 20 presents an excellent solution for oncologists requiring virtuoso performance in oncology care. This venerable 20mg/0.5ml Docetaxel concentrate, supplied in a single sterile vial, is specifically formulated for intravenous, single-dose administration in breast cancer chemotherapy. Manufactured and exported from India, TACEEDO 20MG INJECTION is scarce and highly sought after-making any available deal or offer scarce opportunities to utilise for both practitioners and suppliers. Ready to use and prescription-only, its clear liquid formulation ensures precise dosing and optimal patient safety.
Clinical Application & Specific Usage
TACEEDO 20MG INJECTION is a clear, sterile liquid concentrate utilised primarily in oncology settings for breast cancer treatment. Designed for intravenous administration, its single-dose vial ensures convenience and maximises dosing accuracy. The injection is widely recognised for its efficacy in anticancer protocols and is applied in chemotherapy regimens, offering practitioners a reliable medium for addressing advanced or metastasised breast malignancies. Storage at temperatures below 25C helps preserve its integrity and effectiveness.
Delivery, Policy, and Export Markets
The list price for TACEEDO 20MG INJECTION includes both product and efficient freight management. Dispatching is prompt to ensure timely clinical use, with a transparent sample policy available for large orders. Our main export markets span Asia, Africa, and the Middle East, supported by established supplier relationships. Clients benefit from precise tracking and reliable delivery schedules, making it easier to utilise this unique offering within their oncology practices globally.
FAQ's of TACEEDO 20MG INJECTION:
Q: How is TACEEDO 20MG INJECTION administered?
A: TACEEDO 20MG INJECTION is administered intravenously by a healthcare professional, ensuring precise and controlled delivery of the medication directly into the bloodstream.
Q: What is the primary indication for using TACEEDO 20MG INJECTION?
A: The primary indication for TACEEDO 20MG INJECTION is the treatment of breast cancer. It is commonly used as part of chemotherapy regimens for patients with advanced or metastatic breast cancer.
Q: When should TACEEDO 20MG INJECTION be stored and handled?
A: TACEEDO 20MG INJECTION should be stored below 25C in order to maintain its efficacy and sterility. Always handle according to medical and packaging guidelines to ensure safety.
Q: Where can TACEEDO 20MG INJECTION be exported or supplied?
A: TACEEDO 20MG INJECTION is available for export and supply primarily in regions such as Asia, Africa, and the Middle East, with established distributor networks supporting rapid dispatch.
Q: What are the benefits of using TACEEDO 20MG INJECTION in oncology?
A: This product offers precise, ready-to-use dosing, trusted efficacy as an anticancer agent, and sterility-making it a reliable choice for oncologists treating breast cancer.
Q: How can I utilise an offer or deal on TACEEDO 20MG INJECTION?
A: Contact our sales team or authorised exporters to learn about current promotions, sample policies, or bulk deal opportunities regarding TACEEDO 20MG INJECTION.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese